Health status has improved more in women than in men with rheumatoid arthritis from 1994 to 2009: Results from the Oslo rheumatoid arthritis register

Annals of the Rheumatic Diseases

Volumn 74, Issue 1, 2015, Pages 148-155

  Austad, C ^a   Kvien, T K ^a   Olsen, I C ^a   Uhlig, T ^a  

^a DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE ACTIVITY; DISEASE DURATION; FATIGUE; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MODIFIED HEALTH ASSESSMENT QUESTIONNAIRE; PATIENT GLOBAL ASSESSMENT OF DISEASE; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SHORT FORM 36; SHORT FORM 6D; VISUAL ANALOG SCALE; ARTHRITIS, RHEUMATOID; DAILY LIFE ACTIVITY; MIDDLE AGED; NORWAY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; QUALITY OF LIFE; REGISTER; SEVERITY OF ILLNESS INDEX;

ACTIVITIES OF DAILY LIVING; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NORWAY; PATIENT OUTCOME ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRES; REGISTRIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 84918541790     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204014     Document Type: Article

References (43)

1. Symmons DP, Barrett EM, Bankhead CR, et al. The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol 1994;33:735-9.
2. Kvien TK, Glennås A, Knudsrød OG, et al. The prevalence and severity of rheumatoid arthritis in Oslo. Results from a county register and a population survey. Scand J Rheumatol 1997;26:412-18.
3. Ahlmén M, Svensson B, Albertsson K, et al. Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage. Ann Rheum Dis 2010;69:230-3.
4. Forslind K, Hafström I, Ahlmén M, et al. Sex: a major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis 2007;66:46-52.
5. Jawaheer D, Olsen J, Hetland ML. Sex differences in response to anti-tumor necrosis factor therapy in early and established rheumatoid arthritis-results from the DANBIO registry. J Rheumatol 2012;39:46-53.
6. Kvien TK, Uhlig T, Ødegård S, et al. Epidemiological aspects of rheumatoid arthritis. The sex ratio. Ann N Y Acad Sci 2006;1069:212-22.
7. Katz PP, Criswell LA. Differences in symptom reports between men and women with rheumatoid arthritis. Arthritis Care Res 1996;9:441-8.
8. Barnabe C, Bessette L, Flanagan C, et al. Sex differences in pain scores and localization in inflammatory arthritis: a systematic review and metaanalysis. J Rheumatol 2012;39:1221-30.
9. Jawaheer D, Maranian P, Park G, et al. Disease progression and treatment responses in a prospective DMARD-naive seropositive early rheumatoid arthritis cohort: does gender matter? J Rheumatol 2010;37:2475-85.
10. Gossec L, Baro-Riba J, Bozonnat M-C, et al. Influence of sex on disease severity in patients with rheumatoid arthritis. J Rheumatol 2005;32:1448-51.
11. Sokka T, Kautiainen H, Hannonen P, et al. Changes in health assessment questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population. Arthritis Rheum 2006;54:3113-18.
12. Gardiner PV, Sykes HR, Hassey GA, et al. An evaluation of the health assessment questionnaire in long-term longitudinal follow-up of disability in rheumatoid arthritis. Br J Rheumatol 1993;32:724-8.
13. Ward MM, Leigh JP, Fries JF, et al. Progression of functional disability in patients with rheumatoid arthritis: associations with rheumatology subspeciality care. Arch Intern Med 1993;153:2229-37.
14. Krishnan E, Sokka T, Häkkinen A, et al. Normative values for the health assessment questionnaire disability index. Benchmarking disability in the general population. Arthritis Rheum 2004;50:953-60.
15. Singh JA, Furst DE, Bharat A, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;64:625-39.
16. Smolen JS, Landewé R, Breedveld F, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964-75.
17. Krishnan E, Fries JF. Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998: a longitudinal study of 3035 patients. Am J Med 2003;115:371-6.
18. Welsing PM, Fransen J, Van Riel PL. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis. Arthritis Rheum 2005;52:2616-24.
19. Uhlig T, Heiberg T, Mowinckel P, et al. Rheumatoid arthritis is milder in the new millennium: health status in RA patients 1994-2004. Ann Rheum Dis 2008;67:1710-15.
20. Kvien TK, Uhlig T. The Oslo experience with arthritis registries. Clin Exp Rhematol 2003;31:315-24.
21. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
22. Pincus T, Summey JA, Soraci SA Jr, et al. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983;26:1346-53.
23. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
24. Kvien TK, Kaasa S, Smedstad LM. Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. J Clin Epidemiol 1998;51:1077-86.
25. Ekdahl C, Eberhardt K, Andersson SI, et al. Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford Health Assessment Questionnaire. Scand J Rheumatol 1988;17:263-71.
26. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21:271-92.
27. Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 2005;14:1523-32.
28. Meenan RF, Mason JG, Anderson JJ, et al. AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum 1992;35:1-10.
29. Raza K, Saber TP, Kvien TK, et al. Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials. Ann Rheum Dis 2012;71:1921-3.
30. Ziegler S, Huscher D, Karberg K, et al. Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997-2007: results from the National Database of the German Collaborative Arthritis Centres. Ann Rheum Dis 2011;69:1803-8.
31. Krishnan E, Lingala B, Bruce B, et al. Disability in rheumatoid arthritis in the era of biological treatments. Ann Rheum Dis 2012;71:213-18.
32. Sokka T, Toloza S, Cutolo M, et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study. Arthritis Res Ther 2009;11:R7.
33. Barsky AJ, Peekna HM, Borus JF. Somatic Symptom Reporting in Women and Men. J Gen Intern Med 2001;16:266-75.
34. Björk M, Trupin L, Thyberg I, et al. Differences in activity limitation, pain intensity, and global health in pts with rheumatoid arthritis in Sweden and the USA: a 5-year follow-up. Scand J Rheumatol 2011;40:428-32.
35. Kosinski M, Zhao SZ, Dedhiya S, et al. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum 2000;43:1478-87.
36. Wolfe F, Pincus T. Listening to the patient. A practical guide to self-report questionnaires in clinical care. Arthritis Rheum 1999;42:1797-808.
37. Pope JE, Khanna D, Norrie D, et al. The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials. J Rheumatol 2009;36:254-9.
38. Engelbrecht M, Tarner IH, Van Der Heijde D, et al. Measuring pain and efficacy of pain treatment in inflammatory arthritis: a systematic literature review. J Rheumatol suppl 2012;90:3-10.
39. Wolfe F, Michaud K. Assessment of pain in rheumatoid arthritis: minimal clinically significant difference, predictors, and the effect of anti-tumor necrosis factor therapy. J Rheumatol 2007;34:1674-83.
40. Heiberg T, Kvien TK. Preferences for improved health examined in 1024 patients with rheumatoid arthritis: pain has highest priority. Arthritis Rheum 2002;47:391-7.
41. Heiberg T, Austad C, Kvien TK, et al. Performance of the rheumatoid arthritis impact of disease (RAID) score in relation to other patient-reported outcomes in a register of patients with rheumatoid arthritis. Ann Rheum Dis 2011;70:1080-2.
42. Palm Ø, Purinszky E. Women with early rheumatoid arthritis are referred later than men. Ann Rheum Dis 2005;64:1227-8.
43. Ødegård S, Kvien TK, Uhlig T. Incidence of clinically important 10-year health status and disease activity levels in population-based cohorts with rheumatoid arthritis. J Rheumatol 2008;35:54-60.